Franklin India Multi Cap Fund
The scheme seeks to generate long term capital appreciation by investing in a portfolio of equity and equity related securities of large cap, midcap and small cap companies. There is no assurance that the investment objective of the Scheme will be achieved.
Growthvine rating: 2/5 — ranked #19 of 34 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹10.64 (as of 2026-10-01) |
|---|
| AUM | ₹5,262 Cr |
|---|
| Expense ratio | 1.59% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Akhil Kalluri |
|---|
| Exit load | 1% for redemption within 1 year |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −19.22% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 109.4% of NIFTY500 Multicap 50:25:25's upside and 90.4% of its downside.
Market cap allocation
| Large cap | 26.7% |
|---|
| Mid cap | 37.9% |
|---|
| Small cap | 35.4% |
|---|
Concentration
| Top 5 holdings | 19.4% |
|---|
| Top 10 holdings | 33.8% |
|---|
| Total holdings | 52 |
|---|
| Index overlap | 16.0% |
|---|
| Active share | 84.0% |
|---|
Top holdings
- Hindustan Aeronautics Limited — 5.4%
- Net Asset — 4.3%
- Syrma SGS Technology Limited — 3.8%
- Cyient DLM Limited — 3.6%
- Dixon Technologies (India) Limited — 3.3%
- AXIS Bank Ltd. — 3.3%
- Bosch Ltd — 3.2%
- AIA Engineering Ltd. — 3.0%
- Timken India Ltd — 2.8%
- Data Patterns (India) Limited — 2.8%
Top sectors
- Industrial Products — 18.0%
- Aerospace & Defence — 11.8%
- Pharma & Biotech — 11.5%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.2% | Q2 | #17 of 34 |
| 2025 | 5.0% | Q2 | #9 of 31 |